Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Malaria Journal
Published in: Malaria Journal 1/2018

Open Access 01-12-2018 | Meeting Report

Community participation during two mass anti-malarial administrations in Cambodia: lessons from a joint workshop

Authors: Thomas J. Peto, Mark Debackere, William Etienne, Lieven Vernaeve, Rupam Tripura, Gregoire Falq, Chan Davoeung, Chea Nguon, Huy Rekol, Lorenz von Seidlein, Arjen M. Dondorp, Nou Sanann, Phaik Yeong Cheah, Martin De Smet, Christopher Pell, Jean-Marie Kindermans

Published in: Malaria Journal | Issue 1/2018

Login to get access

Abstract

Two mass drug administrations (MDA) against falciparum malaria were conducted in 2015–16, one as operational research in northern Cambodia, and the other as a clinical trial in western Cambodia. During an April 2017 workshop in Phnom Penh the field teams from Médecins Sans Frontières and the Mahidol-Oxford Tropical Medicine Research Unit discussed lessons for future MDAs.
Literature
1.
Dondorp AM, Yeung S, White L, Nguon C, Day NPJ, Socheat D. Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol. 2010;8:272–80.CrossRefPubMed
2.
von Seidlein L, Dondorp A. Fighting fire with fire: mass antimalarial drug administrations in an era of antimalarial resistance. Expert Rev Anti Infect Ther. 2015;13:715–30.CrossRef
3.
Gerardin J, Eckhoff P, Wenger EA. Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination. BMC Infect Dis. 2015;15:144.CrossRefPubMedPubMedCentral
4.
5.
WHO. Progress on the containment of artemisinin tolerant malaria parasites in South-East Asia (ARCE) initiative. Geneva: World Health Organization; 2010.
6.
Maude RJ, Nguon C, Ly P, Bunkea T, Ngor P, de la Torre SEC, et al. Spatial and temporal epidemiology of clinical malaria in Cambodia 2004–2013. Malar J. 2014;13:385.CrossRefPubMedPubMedCentral
7.
8.
Peto TJ, Kloprogge SE, Tripura R, Nguon C, Sanann N, Yok S, et al. History of malaria treatment as a predictor of subsequent subclinical parasitaemia: a cross-sectional survey and malaria case records from three villages in Pailin, western Cambodia. Malar J. 2016;15:240.CrossRefPubMedPubMedCentral
9.
Tripura R, Peto TJ, Veugen CC, Nguon C, Davoeung C, James N, et al. Submicroscopic Plasmodium prevalence in relation to malaria incidence in 20 villages in western Cambodia. Malar J. 2017;16:56.CrossRefPubMedPubMedCentral
10.
Bosman P, Stassijns J, Nackers F, Canier L, Kim N, Khim S, et al. Plasmodium prevalence and artemisinin-resistant falciparum malaria in Preah Vihear Province, Cambodia: a cross-sectional population-based study. Malar J. 2014;13:394.CrossRefPubMedPubMedCentral
11.
Falq G, Bergh R, De Smet M, Etienne W, Nguon C, Rekol H, et al. Assessing the asymptomatic reservoir and dihydroartemisinin–piperaquine effectiveness in a low transmission setting threatened by artemisinin resistant Plasmodium falciparum. Malar J. 2016;15:446.CrossRefPubMedPubMedCentral
12.
Pell C, Tripura R, Nguon C, Cheah P, Davoeung C, Heng C, et al. Mass anti-malarial administration in western Cambodia: a qualitative study of factors affecting coverage. Malar J. 2017;16:206.CrossRefPubMedPubMedCentral
13.
14.
Adhikari B, Pell C, Phommasone K, Soundala X, Kommarasy P, Pongvongsa T, et al. Elements of effective community engagement: lessons from a targeted malaria elimination study in Lao PDR (Laos). Glob Health Action. 2017;10:1366136.CrossRefPubMedPubMedCentral
15.
Kajeechiwa L, Thwin MM, Shee PW. The acceptability of mass administrations of anti-malarial drugs as part of targeted malaria elimination in villages along the Thai-Myanmar border. Malar J. 2016;15:494.CrossRefPubMedPubMedCentral
Metadata
Title
Community participation during two mass anti-malarial administrations in Cambodia: lessons from a joint workshop
Authors
Thomas J. Peto
Mark Debackere
William Etienne
Lieven Vernaeve
Rupam Tripura
Gregoire Falq
Chan Davoeung
Chea Nguon
Huy Rekol
Lorenz von Seidlein
Arjen M. Dondorp
Nou Sanann
Phaik Yeong Cheah
Martin De Smet
Christopher Pell
Jean-Marie Kindermans
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2018
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-018-2202-z

Other articles of this Issue 1/2018

Malaria Journal 1/2018 Go to the issue

Research

Nationwide insecticide resistance status and biting behaviour of malaria vector species in the Democratic Republic of Congo

Research

Structural patterns of selection and diversity for Plasmodium vivax antigens DBP and AMA1

Research

Potent antiplasmodial extracts and fractions from Terminalia mantaly and Terminalia superba

Research

Uptake of intermittent preventive treatment and pregnancy outcomes: health facilities and community surveys in Chókwè district, southern Mozambique

Research

Malaria programme personnel’s experiences, perceived barriers and facilitators to implementing malaria elimination strategy in South Africa

Review

Insecticide-treated nets mass distribution campaign: benefits and lessons in Zambia
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits